Matthew Ferry and Sarah Bloch authored an article for theDaily Journaldiscussing the top ten aspects alternative protein companies should consider when planning for and negotiating research and commercial agreements.
"Have a clear strategy to protect your background IP [intellectual property]," the authors wrote. "Every inventive step in the development and manufacturing process should be independently protected either as a trade secret or through patents, including any genetic constructs and cell lines, methods of scale-up and manufacture, and the final products. Trade secrets can be valuable but must be subject to reasonable secrecy efforts to be protected in court. Therefore, technologies that are reverse-engineerable from or detectable in products are typically better protected with patents."